Clinical Trial Update: Proton Therapy and Bevacizumab for Primary Liver Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of proton therapy with bevacizumab for primary liver tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer, Hepatocellular Carcinoma | Phase 1 | Status: TERMINATED